Comparison of Instillation and Packing in Mydriasis for Premature Infants

Sponsor
Khon Kaen University (Other)
Overall Status
Completed
CT.gov ID
NCT00877175
Collaborator
(none)
25
1
2
3
8.3

Study Details

Study Description

Brief Summary

The purpose of this study is to compare the mydriatic effect of 2.5% phenylephrine and 1% tropicamide by conventional instillation and lower conjunctival fornix packing in premature infants.

Condition or Disease Intervention/Treatment Phase
  • Drug: 1% tropicamide and 2.5% phenylephrine
Phase 4

Detailed Description

Adequate pupil dilatation was needed for screening and treatment of retinopathy of prematurity (ROP) in premature infants.In general clinical practice, mydriatic drugs were instilled many times until the pupil reached the maximum size. However, poor mydriasis were found in many eyes despite maximum instillation was used. From the clinical observation, we found the packing of mydriatic drugs in lower conjunctival fornix was much more effective to dilate the pupil than instillation in some patients. The purpose of this study was to compare the mydriatic effect of 2.5% phenylephrine and 1% tropicamide by conventional instillation and lower conjunctival fornix packing in premature infants.

Study Design

Study Type:
Interventional
Actual Enrollment :
25 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Diagnostic
Official Title:
Comparison of Conventional Instillation and Lower Conjunctival Fornix Packing in Mydriasis for Premature Infants
Study Start Date :
Mar 1, 2009
Actual Primary Completion Date :
May 1, 2009
Actual Study Completion Date :
Jun 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

Lower conjunctival fornix packing arm. For the eyes receiving lower conjunctival fornix packing (study group), one small piece of the cotton wool soaked with one drop of 2.5% phenylephrine and one drop of 1% tropicamide was packed in the lower conjunctival fornix.

Drug: 1% tropicamide and 2.5% phenylephrine
For the eyes receiving lower conjunctival fornix packing (study group), one small piece of the cotton wool soaked with one drop of 2.5% phenylephrine and one drop of 1% tropicamide was packed in the lower conjunctival fornix. For the eyes receiving the instillation (control group), 2.5% phenylephrine and 1% tropicamide were alternately instilled every 5 minutes for two doses each.

Active Comparator: 2

Conventional instillation arm. For the eyes receiving the instillation (control group), 2.5% phenylephrine and 1% tropicamide were alternately instilled every 5 minutes for two doses each.

Drug: 1% tropicamide and 2.5% phenylephrine
For the eyes receiving lower conjunctival fornix packing (study group), one small piece of the cotton wool soaked with one drop of 2.5% phenylephrine and one drop of 1% tropicamide was packed in the lower conjunctival fornix. For the eyes receiving the instillation (control group), 2.5% phenylephrine and 1% tropicamide were alternately instilled every 5 minutes for two doses each.

Outcome Measures

Primary Outcome Measures

  1. The primary outcome measure was the horizontal pupil diameter measured with a ruler in millimeters [40 minutes after mydriatric drugs]

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Month to 4 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • gestational age of less than 32 weeks and/or the birth weight of less than 1,500 grams

  • stable clinical course

Exclusion Criteria:
  • history of intraocular surgery or laser treatment

  • previous eyedrop instillation that might affect the pupil size

  • severe underlying disease or unstable clinical course that mydriatic drugs or the examination could aggravate their conditions

Contacts and Locations

Locations

Site City State Country Postal Code
1 Srinagarind Hospital Khon Kaen Thailand 40002

Sponsors and Collaborators

  • Khon Kaen University

Investigators

  • Principal Investigator: Yosanan Yospaiboon, M.D., Department of Ophthalmology, Faculty of Medicine, Khon Kaen University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Yosanan Yospaiboon, Professor, Khon Kaen University
ClinicalTrials.gov Identifier:
NCT00877175
Other Study ID Numbers:
  • I50221
  • HE480729
First Posted:
Apr 7, 2009
Last Update Posted:
Mar 9, 2012
Last Verified:
Mar 1, 2012
Keywords provided by Yosanan Yospaiboon, Professor, Khon Kaen University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 9, 2012